Treatment failure of gentamicin in pediatric patients with oropharyngeal tularemia

Medical Science Monitor

Volumn 17, Issue 7, 2011, Pages

  Kaya, Ali ^a   Uysal, Ismail Önder ^a   Güven, Ahmet Sami ^a   Engin, Aynur ^a   Gültürk, Abdulaziz ^a   Içaǧasioǧlu, Füsun D ^a   Cevit, Ömer ^a  

^a CUMHURIYET UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Gentamicin; Oropharyngeal tularemia; Streptomycin; Treatment failure

Indexed keywords

C REACTIVE PROTEIN; CEFAZOLIN; GENTAMICIN; STREPTOMYCIN;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; FRANCISELLA TULARENSIS; HUMAN; INFECTION; LEUKOCYTE COUNT; LYMPH NODE; LYMPHADENOPATHY; MALE; NONHUMAN; OROPHARYNX TULAREMIA; RECURRENT FEVER; RETROSPECTIVE STUDY; SCHOOL CHILD; SEROLOGY; TREATMENT RESPONSE; TULAREMIA; UPPER RESPIRATORY TRACT INFECTION; CLINICAL TRIAL; PATHOLOGY; TREATMENT FAILURE; TURKEY (REPUBLIC);

ADOLESCENT; CHILD; FEMALE; GENTAMICINS; HUMANS; LYMPH NODES; MALE; RETROSPECTIVE STUDIES; STREPTOMYCIN; TREATMENT FAILURE; TULAREMIA; TURKEY;

EID: 79960000751     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/msm.881848     Document Type: Article

References (28)

1. Marinov KT, Georgieva ED, Ivanov IN, Kantardjiev TV: Characterization and genotyping of strains of Francisella tularensis isolated in Bulgaria. J Med Microbiol, 2009; 58: 82-85
2. Sjörstedt A: Tularemia: History, Epidemiology, Pathogen Physiology and Clinical Manifestations. Ann N Y Acad Sci, 2007; 1105: 1-29
3. Sandström G, Sjöstedt A, Forsman M et al: Characterization and classif-cation of strains of Francisella tularensis isolated in the central Asian focus of the Soviet Union and in Japan. J Clin Microbiol, 1992; 30: 172-75
4. Taylor JP, Istre GR, McChesney TC et al: Epidemiological characteristics of human tularemia in the southwest-central states. 1981-1987. Am J Epidemiol, 1991; 133: 1032-38
5. Christova I, Velinov T, Kantardjiev T, Galev A: Tularemia outbreak in Bulgaria. Scand J Infect Dis, 2004; 36: 785-89
6. Celebi S, Hacimustafaoglu M, Gedikoglu S: Tularemia in children. Indian J Pediatr, 2008; 75: 1129-32
7. Tärnvik A, Priebe HS, Grunow R: Tularemia in Europe: an epidemio-logical overview. Scand J Infect Dis, 2004; 36: 350-55
8. Enderlin G, Morales L, Jacobs RF, Cross JT: Streptomycin and alternative agents for the treatment of tularemia: review of the literature. Clin Infect Dis, 1994; 19: 42-47
9. Sawyer WD, Dangerfeld HG, Hogge AL, Crozier D: Antibiotic prophylaxis and therapy of airborne tularemia. Bacteriol Rev, 1966; 30: 542-50
10. Uhari M, Syrjälä H, Salminen A: Tularemia in children caused by Francisella tularensis biovar palaearctica. Pediatr Infect Dis J, 1990; 9: 80-83
11. Koskela P, Herva E: Immunity against Francisella tularensis in northern Finland. Scand J Infect Dis, 1982; 14: 195-99
12. Tärnvik A, Sandström G, Sjöstedt A: Infrequent manifestations of tularaemia in Sweden. Scand J Infect Dis, 1997; 29: 443-46
13. Karadenizli A, Gürcan S, Kolayli F, Vahaboǧlu H: Outbreak of tulare-mia in Golcuk, Turkey in 2005: report of five cases and an overview of the literature from Turkey. Scand J Infect Dis, 2005; 37: 712-16
14. Helvaci S, Gedikoǧlu S, Akalin H, Oral HB: Tularemia in Bursa, Turkey: 205 cases in ten years. Eur J Epidemiol, 2000; 16: 271-76
15. Celebi G, Baruönü F, Ayo ̌glu F et al: Tularemia, a reemerging disease in northwest Turkey: epidemiological investigation and evaluation of treatment responses. Jpn J Infect Dis, 2006; 59: 229-34
16. Willke A, Meric M, Grunow R et al: An outbreak of oropharyngeal tularaemia linked to natural spring water. J Med Microbiol, 2009; 58: 112-16
17. Burkhardt JE, Walterspiel JN, Schaad UB: Quinolone arthropathy in animals versus children. Clin Infect Dis, 1997; 25: 1196-204
18. Nigrovic LE, Wingerter SL: Tularemia. Infect Dis Clin North Am, 2008; 22: 489-504
19. Eliasson H, Broman T, Forsman M, Bäck E: Tularemia: Current epidemiology and disease management. Infect Dis Clin N Am, 2006; 20: 289-311
20. Dennis DT, Inglesby TV, Henderson DA et al: Tularemia as a biological weapon: medical and public health management. JAMA, 2001; 285: 2763-73
21. Kashyap AS, Sharma HS: Discolouration of permanent teeth and enamel hypoplasia due to tetracycline. Postgrad Med J, 1999; 75: 772
22. Chalumeau M, Tonnelier S, D'Athis P et al: Fluoroquinolone safety in pediatric patients: a prospective, multicenter, comparative cohort study in France. Pediatrics, 2003; 111: 714-19
23. Forsythe CT, Ernst ME: Do fuoroquinolones commonly cause arthrop-athy in children. CJEM, 2007; 9: 459-62
24. Johansson A, Berglund L, Gothefors L et al: Ciprofoxacin for treatment of tularemia in children. Pediatr Infect Dis J, 2000; 19: 449-53
25. Amsden JR, Warmack S, Gubbins PO: Tick-borne bacterial, rickettsial, spirochetal, and protozoal infectious diseases in the United States: a comprehensive review. Pharmacotherapy, 2005; 25: 191-210
26. Perez-Castrillon JL, Bachiller-Luque P et al: Tularemia epidemic in northwestern Spain: clinical description and therapeutic response. Clin Infect Dis, 2001; 33: 573-76
27. Risi GF, Pombo DJ: Relapse of tularemia after aminoglycoside therapy: case report and discussion of therapeutic options. Clin Infect Dis, 1995: 20: 174-75
28. Syrjälä H, Schildt R, Räisäinen S: In vitro susceptibility of Francisella tularensis to fuoroquinolones and treatment of tularemia with norfox-acin and ciprofoxacin. Eur J Clin Microbiol Infect Dis, 1991; 10: 68-70